Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer
- 21 August 2018
- journal article
- research article
- Published by SAGE Publications in Acta Radiologica
- Vol. 60 (4) , 441-450
Abstract
Liver magnetic resonance imaging (MRI) provides reliable diagnostic performance for detecting liver metastasis but is costly and time-consuming. To compare the diagnostic performance of non-contrast liver MRI to whole MRI using gadoxetic acid for detecting liver metastasis in patients with colorectal cancer (CRC). We included 175 patients with histologically confirmed 401 liver metastases and 73 benign liver lesions. A non-contrast MRI (T1-weighted, T2-weighted, and diffusion-weighted images) with or without multidetector computed tomography (MDCT) and a whole MRI (gadoxetic acid-enhanced and non-contrast MRI) were analyzed independently by two observers to detect liver metastasis using receiver operating characteristic analysis. We found no significant differences in Az value (range = 0.914–0.997), sensitivity (range = 95.2–99.6%), specificity (range = 77.3–100%), or positive (range = 92.9–100%) or negative predictive value (range = 87.5–95.7%) between the non-contrast MRI with or without MDCT and the whole MRI for both observers for all lesions as well as lesions ≤1.0 cm and lesions >1.0 cm in size (P = 0.203–1.000). Combined MDCT and non-contrast MRI led to similar numbers of false-positive diagnosis to the whole MRI (eight for Observers 1 and 4 vs. 3 for Observer 2). Non-contrast liver MRI may serve as an alternative to gadoxetic acid-enhanced MRI for detecting and characterizing liver metastasis from CRC, at least in patients with relatively high risk of liver metastasis who underwent MDCT. Non-contrast liver MRI could be beneficial especially for patients with lesions that are already documented as benign but require additional follow-up MRIs.Keywords
This publication has 31 references indexed in Scilit:
- MR Imaging in Patients with Suspected Liver Metastases: Value of Liver-Specific Contrast Agent Gadoxetic AcidKorean Journal of Radiology, 2013
- Diagnostic Accuracy and Sensitivity of Diffusion-Weighted and of Gadoxetic Acid-Enhanced 3-T MR Imaging Alone or in Combination in the Detection of Small Liver Metastasis (≤1.5 cm in Diameter)Investigative Radiology, 2012
- Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastasesJournal of Magnetic Resonance Imaging, 2011
- Hepatic Hemangioma and Metastasis: Differentiation With Gadoxetate Disodium–Enhanced 3-T MRIAmerican Journal of Roentgenology, 2010
- Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastasesEuropean Radiology, 2010
- The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: A prospective double-blinded studyEuropean Journal of Radiology, 2007
- Epidemiology and Management of Liver Metastases From Colorectal CancerAnnals of Surgery, 2006
- A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancerBritish Journal of Surgery, 2006
- Does T2-weighted MR imaging improve preoperative detection of malignant hepatic tumors? Observer performance study in 49 surgically proven casesMagnetic Resonance Imaging, 2005
- Follow-up Results After Negative Findings on Unenhanced Hepatic MR Imaging for Hepatic Metastasis from Rectal CancerKorean Journal of Radiology, 2004